Dow Jones on pace for lowest close since May 4

10 Best “Strong Buy” Stocks — IMKTA HOLX CBPO and more

Portfolio Grader gives these picks top marks in several categories

By Portfolio Grader

http://invstplc.com/1JM1NAt

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

Since the first of the year, the price of Ingles Markets, Incorporated Class A (IMKTA) has swelled 47.9%. Ingles Markets operates a supermarket chain in the southeastern United States. For more information, get Portfolio Grader’s complete analysis of IMKTA stock.

Shares of Hologic, Inc. (HOLX) have risen 48% since January 1. Hologic develops, manufactures, and markets x-ray systems. For more information, get Portfolio Grader’s complete analysis of HOLX stock.

Shares of China Biologic Products, Inc. (CBPO) have leaped 49.3% since January 1. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

The price of Ebix, Inc. (EBIX) has seen a 68.9% boost since the first of the year. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

The price of Stamps.com (STMP) is up 76.3% since the first of the year. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.

Ellie Mae, Inc. (ELLI) has risen 83.4% since the first of the year. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

Since January 1, Sucampo Pharmaceuticals, Inc. Class A (SCMP) has climbed 108.1%. Sucampo Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Trade volume rose notably over the past week, up 95.1%. For more information, get Portfolio Grader’s complete analysis of SCMP stock.

Since January 1, Skechers U.S.A., Inc. Class A (SKX) has shot up 151.3%. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Since January 1, ABIOMED, Inc. (ABMD) has jumped 167.6%. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Since January 1, the price of Chimera Investment Corporation (CIM) has grown 308.8%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock’s trailing PE Ratio is 5.10. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/09/10-best-strong-buy-stocks-imkta-holx-cbpo-and-more-imkta-holx-cbpo-2/.

©2018 InvestorPlace Media, LLC